Skip to main content

Table 3 Comparison between those who had atherosclerotic vascular disease and those without atherosclerotic vascular disease among kidney disease patients

From: Atherosclerotic vascular disease is more prevalent among black ESKD patients on long-term CAPD in South Africa

Risk factors AsVD present (n = 66) AsVD Absent (n = 54) p-value
Age 43.5 (36.0–50.0) 37.0 (30.0–44.0) 0.002*
BMI 27.0 (22.5–31.9) 26.4 (22.0–30.5) 0.394
WHR 0.92 (0.88–0.96) 0.89 (0.85–0.94) 0.028*
SBP 148.5 (131.0–164.0) 147.0 (127–167) 0.411
MABP 139.8 (116.3–161.0) 141.8 (130.3–155.3) 0.792
TC 4.4 (3.4–5.3) 4.1 (3.5–4.7) 0.342
TG 1.2 (0.8–1.6) 1.3 (0.7–1.8) 0.444
LDL 2.5 (1.7–3.3) 2.3 (1.8–2.7) 0.150
HDL 1.2 (1.0–1.4) 1.1 (0.9–1.4) 0.065
Castelli1 3.5 (2.8–4.4) 3.6 (3.1–4.6) 0.560
Castelli2 1.9 (1.5–2.9) 2.0 (1.6–2.6) 0.914
AC 2.5 (1.8–3.4) 2.6 (2.1–3.6) 0.560
AIP 0.0 (−0.5–0.4) 0.1 (− 0.4–0.4) 0.202
non-HDL 3.2 (2.3–4.1) 3.0 (2.5–3.3) 0.518
LCI 9.5 (4.8–21.7) 10.1 (4.8–18.3) 0.868
EF 58.5 (53.0–64.0) 61.0 (56.0–64.0) 0.257
LAD 3.9 (3.5–4.5) 3.8 (3.2–4.2) 0.050
LVMI 122.9 (103.5–146.0) 98.6 (83.0–117.1) < 0.001*
FRS 7.5 (3.0–11.0) 5 (0–9.0) 0.036
Risk of CHD (%) 2.0 (1.0–5.0) 0.8 (0.5–1.0) < 0.001*
  1. * - statistically significant, p < 0.05, AsVD Atherosclerotic vascular disease, BMI Body mass index, WHR Waist-hip ratio, SBP Systolic blood pressure, MABP Mean arterial blood pressure, TC Total cholesterol, TG Triglyceride, LDL-C Low density lipoprotein, HDL-C High density lipoprotein, SCr Serum creatinine, eGFR Estimated glomerular filtration rate, CaXPO4 Calcium-phosphate product, AC Atherogenic coefficient, AIP Atherogenic index of plasma, non-HDL-C- non- high density lipoprotein, LCI Lipoprotein combine index, EF Ejection fraction, LAD Left atrial diameter, LVM Left ventricular mass, LVMI Left ventricular mass index, FRS Framingham risk score, Risk of CHD – 10-year risk of coronary heart disease
\